Finance

Lists
GRDN:NYSE
Guardian Pharmacy Services Inc
41,28 USD
-0,81%
(-0,34) 1D
41,28 USD
0,00% (0,00)
After hours
Closed: 9-окт., 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GRDN...
Open
41,43 USD
High
41,48 USD
Low
40,67 USD
Mkt. cap
2,61 млд
Avg. vol.
634,50 миң
Volume
397,51 миң
P/E ratio
40,40
52-wk high
48,33 USD
52-wk low
23,14 USD
EPS
1,02 USD
Shares outstanding
49,80 млн
No. of employees
4 миң
Open
41,43 USD
High
41,48 USD
Low
40,67 USD
Mkt. cap
2,61 млд
Avg. vol.
634,50 миң
Volume
397,51 миң
P/E ratio
40,40
52-wk high
48,33 USD
52-wk low
23,14 USD
EPS
1,02 USD
Shares outstanding
49,80 млн
No. of employees
4 миң
News stories
From web sources and news partners
About Guardian Pharmacy Services Inc
CEO-
Employees3,6 миң
Founded2003
HeadquartersАтланта, Джорджия, Америка Кошмо Штаттары
SectorHealth care provider
Analyst ratings
Based on 5 analysts giving stock ratings to GRDN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GRDN in the last 3 months.
Highest
Current 41,28 USD
52,00 USD (+25,97%)
Average
49,80 USD (+20,64%)
Lowest
47,00 USD (+13,86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Gillmor CFA
KeyBanc
Buy
Initiated
52,00 USD
+26%
09/22/2026
Zach Haggerty‏
KeyBanc
Buy
Initiated
52,00 USD
+26%
09/22/2026
Unknown Analyst
KeyBanc
Buy
Initiated
52,00 USD
+26%
09/22/2026
David S Macdonald
Truist Financial
Buy
Maintained
51,00 USD
+23,5%
09/21/2026
Allen Lutz
Bank of America Securities
Buy
Reiterated
47,00 USD
+13,9%
09/01/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
49,00 USD
+18,7%
08/07/2026
Unknown Analyst
Stephens
Buy
Reiterated
50,00 USD
+21,1%
08/07/2026
Richard Newitter
Truist Financial
Buy
Maintained
47,00 USD
+13,9%
06/22/2026
Brian Tanquilut
Jefferies
Buy
Reiterated
50,00 USD
+21,1%
06/15/2026
Last report
2026-ж., 6-авг.
Fiscal period
Q2 2026
0,29 USD / 0,26 USD
+10,83%beat
Revenue / Est. (USD)
351,77 млн / 339,99 млн
+3,46%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
377,43 млн
397,62 млн
336,60 млн
351,77 млн
Cost of goods sold
302,71 млн
312,11 млн
260,29 млн
271,72 млн
Cost of revenue
302,71 млн
312,11 млн
260,29 млн
271,72 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57,82 млн
50,14 млн
55,43 млн
67,80 млн
Operating expense
57,82 млн
50,14 млн
55,43 млн
67,80 млн
Total operating expenses
360,53 млн
362,25 млн
315,72 млн
339,53 млн
Operating income
16,90 млн
35,37 млн
20,88 млн
12,24 млн
Other non operating income
437,00 миң
500,00 миң
772,00 миң
9,30 млн
EBT including unusual items
16,63 млн
31,10 млн
18,29 млн
29,79 млн
EBT excluding unusual items
17,18 млн
35,70 млн
21,50 млн
21,39 млн
Income tax expense
7,04 млн
9,83 млн
4,75 млн
7,67 млн
Effective tax rate
42,32%
31,62%
25,96%
25,75%
Other operating expenses
-
-
-
-
Net income
9,82 млн
20,92 млн
13,30 млн
21,87 млн
Net profit margin
2,60%
5,26%
3,95%
6,22%
Earnings per share
0,25
0,37
0,29
0,29
Interest and investment income
-
-
-
-
Interest expense
-160,00 миң
-163,00 миң
-154,00 миң
-154,00 миң
Net interest expenses
-160,00 миң
-163,00 миң
-154,00 миң
-154,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
22,74 млн
41,11 млн
26,85 млн
18,05 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору